Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ZANAMIVIR vs ZANIDATAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ZANAMIVIR vs ZANIDATAMAB: Safety Overview

Metric ZANAMIVIR ZANIDATAMAB
Total FAERS Reports 384 142
Deaths Reported 123 12
Death Rate 32.0% 8.5%
Hospitalizations 112 125
Average Patient Age 38.4 yrs 65.2 yrs
% Female Patients 49.8% 40.2%
FDA Approval Date Jul 26, 1999 N/A
Manufacturer GlaxoSmithKline LLC Jazz Pharmaceuticals, Inc.
Route RESPIRATORY (INHALATION) INTRAVENOUS
Marketing Status Prescription N/A